Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.

Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.

BACKGROUND:Personalized treatment for cancer patients is a hot topic of debate, particularly the decision to initiate chemotherapy in patients with Estrogen receptor (ER)-positive, HER2-negative tumors in the early stages of breast cancer (BC). Owing to significant advancements in information techno...

Full description

Bibliographic Details
Main Authors: Yun Yeong Kim, Se Jeong Oh, Yong Soon Chun, Woon Kee Lee, Heung Kyu Park
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6034851?pdf=render

Internet

http://europepmc.org/articles/PMC6034851?pdf=render

Similar Items